NCT06810609
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06810609
Title Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC (InDuRanS)
Acronym InDuRanS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Hospital, Bonn
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
University Hospital Freiburg RECRUITING Freiburg im Breisgau Baden-Wurttemberg 79106 Germany Details
Klinikum Stuttgart RECRUITING Stuttgart Baden-Wurttemberg 70174 Germany Details
University Hospital Gießen NOT_YET_RECRUITING Giessen Hesse 35392 Germany Details
Johannes Wesling Klinikum Minden Mühlenkreiskliniken, Hämatologie und Onkologie RECRUITING Minden North Rhine-Westphalia 32429 Germany Details
University Hospital Bonn RECRUITING Bonn 53127 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field